Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy

In Vivo

Volumn 18, Issue 1, 2004, Pages 37-42

  Vogel, Ida ^a   Grønbaek, Henning ^a   Thorsen, Poul ^b,c   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Albumin; Alcohol; IGF; IGFBP 1; Preterm delivery

Indexed keywords

BIOCHEMICAL MARKER; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ALCOHOL CONSUMPTION; AMNION FLUID; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PATIENT SELECTION; PREDICTION; PREGNANCY DISORDER; PREMATURE LABOR; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VAGINA DISCHARGE; VAGINITIS;

EID: 1342347363     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bach LA and Rechler MM: Insulin-like growth factor binding proteins. Diabetes Reviews 3(1): 38-61, 1995.
2. Frystyk J, Skjaerbaek C, Dinesen B and Orskov H: Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348 (2): 185-191, 1994.
3. Rutanen EM, Karkkainen TH, Lehtovirta J, Uotila JT, Hinkula MK and Hartikainen AL: Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 253 (1-2): 91-101, 1996.
4. Kekki M, Kurki T, Karkkainen T, Hiilesmaa V, Paavonen J and Rutanen EM: Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 80 (6): 546-551, 2001.
5. Lembet A, Eroglu D, Ergin T, Kuscu E, Zeyneloglu H, Batioglu S and Haberal A: New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions. Acta Obstet Gynecol Scand 81 (8): 706-712, 2002.
6. Nuutila M, Hiilesmaa V, Karkkainen T, Ylikorkala O and Rutanen EM: Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol 94 (2): 243-249, 1999.
7. Thorsen P, Schendel DE, Deshpande AD, Vogel I, Dudley DJ and Olsen J: Identification of biological/biochemical marker(s) for preterm delivery. Paediatr Perinat Epidemiol 15 Suppl 2: 90-103, 2001.
8. Thorsen P, Jensen IP and Ebbesen N: Few microorganisms may constitute the pathological core of bacterial vaginosis. A population based microbiological study among 3596 pregnant women. Am J Obstet Gynecol 178: 580-587, 1998.
9. Christensen CK and Ørskov C: Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabetic Nephrology 3: 92-94, 1984.
10. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D and Holmes K: Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74: 14-22, 1983.
11. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L and Garite TJ: Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery [see comments]. N Engl J Med 325: 669-674, 1991.
12. Kesmodel U, Olsen SF and Secher NJ: Does alcohol increase the risk of preterm delivery? Epidemiology 11 (5): 512-518, 2000.
13. Passaro KT, Little RE, Savitz DA and Noss J: The effect of maternal drinking before conception and in early pregnancy on infant birthweight. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Epidemiology 7 (4): 377-383, 1996.
14. Kesmodel U and Olsen SF: Self reported alcohol intake in pregnancy: comparison between four methods. J Epidemiol Community Health 55 (10): 738-745, 2001.
15. Rojdmark S, Rydvald Y, Aquilonius A and Brismar K: Insulin-like growth factor (IGF)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability. Clin Endocrinol (Oxf) 52 (3): 313-318, 2000.
16. Lang CH, Fan J, Lipton BP, Potter BJ and McDonough KH: Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 22 (4): 823-829, 1998.
17. Fatayerji N, Engelmann GL, Myers T and Handa RJ: In utero exposure to ethanol alters mRNA for insulin-like growth factors and insulin-like growth factor-binding proteins in placenta and lung of fetal rats. Alcohol Clin Exp Res 20 (1): 94-100, 1996.
18. Chard T: Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 4 (3): 91-100, 1994.
19. Fant M, Salafia C, Baxter RC, Schwander J, Vogel C, Pezzullo J and Moya F: Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept 48 (1-2): 29-39, 1993.
20. Cianfarani S, Germani D, Rossi P, Rossi L, Germani A, Ossicini C, Zuppa A, Argiro G, Holly JM and Branca F: Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life. Pediatr Res 44 (3): 374-380, 1998.
21. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1): 3-34, 1995.
22. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M and Binoux M: Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 138 (7): 2937-2947, 1997.
23. Kekki M, Kurki T, Paavonen J and Rutanen EM: Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet 353 (9163): 1494, 1999.